What a records-based opinion can and cannot settle
If you are considering care in China for brain metastases, the practical question is not whether records are useful. They are. The question is which decisions can be made from a file and which genuinely require a clinician to examine you. Getting this distinction right prevents two opposite mistakes: travelling before anyone has looked at your case, or waiting at home for a definitive answer that no remote review can honestly give.
A records-based opinion can review your imaging, pathology, prior treatments and current symptoms, then explain which approaches are worth discussing. It can identify missing information and flag questions for the treating team. What it cannot do is confirm your fitness for a procedure, judge how a lesion is responding to treatment right now, or commit a hospital to accepting you. Those are clinical and institutional decisions made in person.
This matters because brain metastases are rarely a single-disease problem. Your primary cancer, any previous brain treatment, and your current systemic therapy all interact. A plan that looks reasonable on paper can change once a clinician examines your neurological status and reviews the actual images.
Questions that usually need a clinician in the room
Some questions are answerable only through direct assessment. Whether a specific treatment is suitable for you is one. Suitability depends on the size, number and location of lesions, your symptoms, your overall condition and what treatment you have already had. A clinician needs to examine you and review your imaging to judge this.
How your symptoms are changing is another. New headaches, seizures, weakness or changes in speech or vision need prompt local assessment, not an overseas enquiry. If your symptoms are worsening, seek care where you are before planning travel.
How brain-directed treatment should be sequenced with your systemic cancer treatment is a third. This requires coordination between specialties and knowledge of your current regimen. It is a decision for the treating team, not something a records summary can settle.
Whether you are fit to travel and when is also an in-person judgement. A clinician who has examined you can advise on this; a remote reviewer cannot.
The records that make an assessment possible
A useful review starts with a clear picture of your cancer and your brain. Gather your primary cancer records: the original pathology report, staging information and a summary of treatments you have received, including surgery, radiotherapy, chemotherapy, targeted therapy or immunotherapy.
For the brain specifically, include your most recent brain imaging reports and, where possible, the images themselves. If you have had previous brain radiotherapy or surgery, records of that treatment help the team understand what has already been done and what options remain.
Also include a current medication list, recent blood tests and a short note in your own words about your main question and your symptoms. You do not need to send a complete archive at first contact. A brief summary is enough to start, and the team can tell you what else is needed.
Why the treatment plan is individual, not standard
Radiotherapy is one option that may be discussed for brain metastases. It uses radiation to treat cancer, and the technique and schedule depend on the individual treatment plan. That is the key point: there is no single schedule that applies to everyone, and the details are set by the treating team after assessment.
This is why questions about dose, number of sessions or timing cannot be answered from a general article or a records summary alone. They depend on your imaging, your symptoms and your overall treatment plan. A clinician who has assessed you can explain the reasoning; a remote reviewer can only outline what might be considered.
The same applies to other approaches. Whether surgery, radiotherapy, systemic therapy or a combination is appropriate is a decision that requires direct assessment. A records-based opinion can help you understand the landscape, but it does not replace that decision.
What to ask before you travel
Before committing to travel, ask the hospital or coordinating team specific questions. What information do they need to review your case? Will the review be records-based or will it require an in-person visit? Who will make the final decision about suitability, and when? Ask what the written estimate or plan includes and what remains undecided until you are seen. Ask whether the specialist you are hoping to see will actually be involved in your assessment, and what the process is if your case needs input from more than one specialty. These questions help you understand what can be settled remotely and what cannot, and they help you avoid arriving without a clear plan for who will assess you and what happens next.
A records-based opinion can be genuinely useful, but it has a boundary. It can review your imaging, pathology and treatment history, explain which approaches are worth discussing, and identify what information is missing. It cannot confirm your fitness for a procedure, judge how a lesion is responding right now, or commit a hospital to accepting you. Those are clinical and institutional decisions made after a clinician examines you and reviews the actual images. Knowing where that line falls is what stops you from either travelling before anyone has looked at your case or waiting at home for a definitive answer that no remote review can honestly give.
Some questions are answerable only through direct assessment, and it is worth naming them clearly so you know what to expect. Whether a specific treatment is suitable for you is one: suitability depends on the size, number and location of lesions, your symptoms, your overall condition and what treatment you have already had. How your symptoms are changing is another, and new headaches, seizures, weakness or changes in speech or vision need prompt local assessment rather than an overseas enquiry. How brain-directed treatment should be sequenced with your systemic cancer treatment is a third, because it requires coordination between specialties and knowledge of your current regimen. Whether you are fit to travel, and when, is also an in-person judgement.
The records you gather shape how useful any review can be. Start with your primary cancer records: the original pathology report, staging information and a summary of treatments you have received, including surgery, radiotherapy, chemotherapy, targeted therapy or immunotherapy. For the brain specifically, include your most recent brain imaging reports and, where possible, the images themselves. If you have had previous brain radiotherapy or surgery, records of that treatment help the team understand what has already been done and what options remain. A current medication list, recent blood tests and a short note in your own words about your main question and your symptoms complete the picture. You do not need to send a complete archive at first contact; a brief summary is enough to start, and the team can tell you what else is needed.
Radiotherapy is one option that may be discussed for brain metastases. It uses radiation to treat cancer, and the technique and schedule depend on the individual treatment plan. That is the key point: there is no single schedule that applies to everyone, and the details are set by the treating team after assessment. This is why questions about dose, number of sessions or timing cannot be answered from a general article or a records summary alone. They depend on your imaging, your symptoms and your overall treatment plan. A clinician who has assessed you can explain the reasoning; a remote reviewer can only outline what might be considered. The same applies to other approaches, because whether surgery, radiotherapy, systemic therapy or a combination is appropriate is a decision that requires direct assessment.
ChinaSpecialistCare provides non-clinical coordination for international patients. We can help you organise your records, request a specialist appointment, and arrange interpretation and practical support during a visit. We do not diagnose, prescribe or decide suitability; those decisions belong to the treating hospital and licensed clinicians. If you would like to start, you can send a brief summary of your case through the enquiry form, email or WhatsApp. An initial enquiry is free and does not require buying a proxy consultation. We will check what you have, identify what is missing and suggest the relevant next step. For more detail on radiotherapy planning in China, see our precision radiotherapy reference, which explains the general process and what to prepare while the specific decisions remain with your treating team.
How ChinaSpecialistCare can help with the practical steps
ChinaSpecialistCare provides non-clinical coordination for international patients. We can help you organise your records, request a specialist appointment, and arrange interpretation and practical support during a visit. We do not diagnose, prescribe or decide suitability; those decisions belong to the treating hospital and licensed clinicians.
If you would like to start, you can send a brief summary of your case through the enquiry form, email or WhatsApp. An initial enquiry is free and does not require buying a proxy consultation. We will check what you have, identify what is missing and suggest the relevant next step.
For more detail on radiotherapy planning in China, see our precision radiotherapy reference. It explains the general process and what to prepare, while the specific decisions remain with your treating team.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.